|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 |
multiple interactions |
ISO |
Am 580 promotes the reaction [Tretinoin results in increased expression of ABCG2 mRNA] |
CTD |
PMID:20562004 |
|
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
|
|
G |
Ada |
adenosine deaminase |
increases expression |
ISO |
Am 580 results in increased expression of ADA mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 3:152,398,745...152,422,854
Ensembl chr 3:152,398,747...152,447,088
|
|
G |
Agpat4 |
1-acylglycerol-3-phosphate O-acyltransferase 4 |
increases expression |
ISO |
Am 580 results in increased expression of AGPAT4 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 1:48,525,131...48,633,798
Ensembl chr 1:48,527,323...48,633,345
|
|
G |
Agrn |
agrin |
decreases expression |
ISO |
Am 580 results in decreased expression of AGRN mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 5:166,749,306...166,782,212
Ensembl chr 5:166,749,310...166,786,003
|
|
G |
Ajap1 |
adherens junctions associated protein 1 |
increases expression |
ISO |
Am 580 results in increased expression of AJAP1 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 5:163,907,846...164,021,004
Ensembl chr 5:163,907,847...164,020,317
|
|
G |
Aplp2 |
amyloid beta precursor like protein 2 |
increases expression |
ISO |
Am 580 results in increased expression of APLP2 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 8:29,599,230...29,662,311
Ensembl chr 8:29,599,230...29,661,855
|
|
G |
Ar |
androgen receptor |
decreases activity |
ISO |
Am 580 results in decreased activity of AR protein |
CTD |
PMID:25257666 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Atp2b1 |
ATPase plasma membrane Ca2+ transporting 1 |
decreases expression |
ISO |
Am 580 results in decreased expression of ATP2B1 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 7:33,735,595...33,845,226
Ensembl chr 7:33,735,871...33,843,295
|
|
G |
Bag2 |
BAG cochaperone 2 |
increases expression |
ISO |
Am 580 results in increased expression of BAG2 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 9:35,970,033...35,980,677
Ensembl chr 9:35,970,033...35,980,721
|
|
G |
C19h16orf46 |
similar to human chromosome 16 open reading frame 46 |
decreases expression |
ISO |
Am 580 results in decreased expression of C16ORF46 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr19:45,017,499...45,033,453
Ensembl chr19:45,022,280...45,032,683
|
|
G |
Calcrl |
calcitonin receptor like receptor |
decreases expression |
ISO |
Am 580 results in decreased expression of CALCRL mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 3:69,428,348...69,525,910
Ensembl chr 3:69,430,120...69,525,910
|
|
G |
Capn1 |
calpain 1 |
decreases expression decreases activity |
ISO |
Am 580 results in decreased expression of CAPN1 mRNA Am 580 results in decreased activity of CAPN1 protein |
CTD |
PMID:17460283 |
|
NCBI chr 1:203,275,912...203,300,848
Ensembl chr 1:203,277,344...203,300,177
|
|
G |
Capn2 |
calpain 2 |
decreases expression multiple interactions decreases activity |
ISO |
Am 580 results in decreased expression of CAPN2 mRNA Am 580 inhibits the reaction [Hydrogen Peroxide results in increased activity of CAPN2 protein]; Am 580 inhibits the reaction [Hydrogen Peroxide results in increased expression of CAPN2 mRNA] Am 580 results in decreased activity of CAPN2 protein |
CTD |
PMID:17460283 |
|
NCBI chr13:94,150,244...94,200,969
Ensembl chr13:94,150,240...94,200,969
|
|
G |
Cd1d1 |
CD1d1 molecule |
increases expression multiple interactions |
ISO |
Am 580 results in increased expression of CD1D mRNA Ro 41-5253 inhibits the reaction [Am 580 results in increased expression of CD1D mRNA] |
CTD |
PMID:16982809 PMID:17392484 |
|
NCBI chr 2:172,423,582...172,427,089
Ensembl chr 2:172,423,582...172,427,089
|
|
G |
Cd300a |
Cd300a molecule |
increases expression |
ISO |
Am 580 results in increased expression of CD300A mRNA |
CTD |
PMID:16982809 |
|
NCBI chr10:99,929,801...99,942,674
Ensembl chr10:99,929,801...99,942,674
|
|
G |
Cd300lb |
CD300 molecule-like family member b |
increases expression |
ISO |
Am 580 results in increased expression of CD300LB mRNA |
CTD |
PMID:16982809 |
|
NCBI chr10:99,964,801...99,974,790
Ensembl chr10:99,964,801...99,974,790
|
|
G |
Cd300lf |
Cd300 molecule-like family member F |
increases expression |
ISO |
Am 580 results in increased expression of CD300LF mRNA |
CTD |
PMID:16982809 |
|
NCBI chr10:100,359,942...100,376,130
Ensembl chr10:100,359,943...100,376,041
|
|
G |
Cd38 |
CD38 molecule |
increases expression multiple interactions |
ISO |
Am 580 results in increased expression of CD38 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Am 580 results in increased expression of CD38 protein]; [Ro 25-6603 co-treated with Am 580] results in increased expression of CD38 protein |
CTD |
PMID:16329108 |
|
NCBI chr14:67,172,062...67,212,328
Ensembl chr14:67,172,063...67,211,986
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
affects localization |
ISO |
Am 580 affects the localization of CDKN1B protein |
CTD |
PMID:16618747 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Cdr2l |
cerebellar degeneration-related protein 2-like |
decreases expression |
ISO |
Am 580 results in decreased expression of CDR2L mRNA |
CTD |
PMID:16982809 |
|
NCBI chr10:100,625,150...100,638,669
Ensembl chr10:100,624,607...100,638,666
|
|
G |
Col5a3 |
collagen type V alpha 3 chain |
increases expression |
ISO |
Am 580 results in increased expression of COL5A3 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 8:19,304,564...19,349,809
Ensembl chr 8:19,304,571...19,349,853
|
|
G |
Cttnbp2 |
cortactin binding protein 2 |
decreases expression |
ISO |
Am 580 results in decreased expression of CTTNBP2 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 4:46,800,975...46,964,681
Ensembl chr 4:46,800,981...46,964,631
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
increases expression |
ISO |
Am 580 results in increased expression of CYP19A1 mRNA |
CTD |
PMID:15941851 |
|
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Cyp26a1 |
cytochrome P450, family 26, subfamily a, polypeptide 1 |
multiple interactions increases expression |
ISO |
Ro 41-5253 inhibits the reaction [Am 580 results in increased expression of CYP26A1 mRNA] |
CTD |
PMID:10953040 |
|
NCBI chr 1:235,471,368...235,475,204
Ensembl chr 1:235,471,298...235,475,204
|
|
G |
Dcstamp |
dendrocyte expressed seven transmembrane protein |
increases expression |
ISO |
Am 580 results in increased expression of DCSTAMP mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 7:70,807,455...70,822,067
Ensembl chr 7:70,807,581...70,822,078
|
|
G |
Dhrs3 |
dehydrogenase/reductase 3 |
increases expression |
ISO |
Am 580 results in increased expression of DHRS3 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 5:156,747,939...156,782,420
Ensembl chr 5:156,747,962...156,782,417
|
|
G |
Dmpk |
DM1 protein kinase |
decreases expression |
ISO |
Am 580 results in decreased expression of DMPK mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 1:78,730,255...78,740,585
Ensembl chr 1:78,730,275...78,740,593
|
|
G |
Dmwd |
DM1 locus, WD repeat containing |
decreases expression |
ISO |
Am 580 results in decreased expression of DMWD mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 1:78,722,436...78,729,224
Ensembl chr 1:78,722,330...78,740,593
|
|
G |
Dnajc5b |
DnaJ heat shock protein family (Hsp40) member C5 beta |
increases expression |
ISO |
Am 580 results in increased expression of DNAJC5B mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 2:101,973,726...102,066,275
Ensembl chr 2:101,973,793...102,066,275
|
|
G |
Ets2 |
ETS proto-oncogene 2, transcription factor |
increases expression |
ISO |
Am 580 results in increased expression of ETS2 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr11:35,021,536...35,038,322
Ensembl chr11:35,021,596...35,038,319
|
|
G |
Fam241a |
family with sequence similarity 241 member A |
decreases expression |
ISO |
Am 580 results in decreased expression of FAM241A mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 2:216,344,563...216,375,193
Ensembl chr 2:216,343,822...216,375,242
|
|
G |
Fas |
Fas cell surface death receptor |
increases activity |
ISO |
Am 580 results in increased activity of FAS protein |
CTD |
PMID:15703382 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Fn1 |
fibronectin 1 |
increases expression |
ISO |
Am 580 results in increased expression of FN1 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Fut7 |
fucosyltransferase 7 |
decreases expression |
ISO |
Am 580 results in decreased expression of FUT7 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 3:8,237,687...8,242,273
Ensembl chr 3:8,239,384...8,242,260
|
|
G |
Galm |
galactose mutarotase |
increases expression |
ISO |
Am 580 results in increased expression of GALM mRNA |
CTD |
PMID:18052213 |
|
NCBI chr 6:14,837,540...14,889,484
Ensembl chr 6:14,837,548...14,889,310
|
|
G |
Gdf15 |
growth differentiation factor 15 |
increases expression |
ISO |
Am 580 results in increased expression of GDF15 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
|
|
G |
Gpd1l |
glycerol-3-phosphate dehydrogenase 1 like |
decreases expression |
ISO |
Am 580 results in decreased expression of GPD1L mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 8:114,591,103...114,620,771
Ensembl chr 8:114,588,487...114,620,723
|
|
G |
Gusb |
glucuronidase, beta |
increases expression |
ISO |
Am 580 results in increased expression of GUSB mRNA |
CTD |
PMID:16982809 |
|
NCBI chr12:26,701,188...26,714,718
Ensembl chr12:26,697,951...26,726,905
|
|
G |
Hipk2 |
homeodomain interacting protein kinase 2 |
increases expression |
ISO |
Am 580 results in increased expression of HIPK2 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 4:67,439,327...67,619,223
Ensembl chr 4:67,440,501...67,619,223
|
|
G |
Hist1h2bd |
histone cluster 1 H2B family member D |
decreases expression |
ISO |
Am 580 results in decreased expression of H2BC5 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr17:42,792,887...42,793,268
|
|
G |
Hlx |
H2.0-like homeobox |
decreases expression |
ISO |
Am 580 results in decreased expression of HLX mRNA |
CTD |
PMID:16982809 |
|
NCBI chr13:96,280,335...96,285,750
Ensembl chr13:96,280,339...96,285,750
|
|
G |
Ifngr1 |
interferon gamma receptor 1 |
multiple interactions increases expression |
ISO |
Ro 41-5253 inhibits the reaction [Am 580 results in increased expression of IFNGR1 protein] |
CTD |
PMID:16085646 |
|
NCBI chr 1:14,333,167...14,351,799
Ensembl chr 1:14,333,187...14,351,785
|
|
G |
Il1r1 |
interleukin 1 receptor type 1 |
decreases expression |
ISO |
Am 580 results in decreased expression of IL1R1 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 9:42,504,917...42,580,958
Ensembl chr 9:42,504,735...42,579,937
|
|
G |
Il1rap |
interleukin 1 receptor accessory protein |
decreases expression |
ISO |
Am 580 results in decreased expression of IL1RAP mRNA |
CTD |
PMID:16982809 |
|
NCBI chr11:74,062,999...74,199,530
Ensembl chr11:74,070,304...74,199,530
|
|
G |
Inpp5f |
inositol polyphosphate-5-phosphatase F |
increases expression |
ISO |
Am 580 results in increased expression of INPP5F mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 1:183,190,480...183,270,276
Ensembl chr 1:183,190,480...183,270,276
|
|
G |
Ipcef1 |
interaction protein for cytohesin exchange factors 1 |
decreases expression |
ISO |
Am 580 results in decreased expression of IPCEF1 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 1:43,237,903...43,451,735
Ensembl chr 1:43,269,202...43,427,969
|
|
G |
Irf1 |
interferon regulatory factor 1 |
multiple interactions increases expression increases activity |
ISO |
Am 580 affects the localization of [Am 580 results in increased expression of IRF1 protein]; Ro 41-5253 inhibits the reaction [Am 580 results in increased expression of IRF1 protein]; Tretinoin promotes the reaction [Am 580 results in increased activity of IRF1 protein] |
CTD |
PMID:16085646 PMID:16636311 |
|
NCBI chr10:37,917,155...37,924,166
Ensembl chr10:37,916,670...37,924,166
|
|
G |
Itgae |
integrin subunit alpha E |
increases expression |
ISO |
Am 580 results in increased expression of ITGAE mRNA |
CTD |
PMID:16982809 |
|
NCBI chr10:57,704,813...57,764,093
Ensembl chr10:57,591,753...57,764,093 Ensembl chr10:57,591,753...57,764,093
|
|
G |
Kiaa0040 |
KIAA0040 ortholog |
decreases expression |
ISO |
Am 580 results in decreased expression of KIAA0040 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr13:72,274,519...72,312,103
Ensembl chr13:72,274,552...72,312,103
|
|
G |
Kifc2 |
kinesin family member C2 |
decreases expression |
ISO |
Am 580 results in decreased expression of KIFC2 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 7:108,380,634...108,388,364
Ensembl chr 7:108,376,011...108,388,484
|
|
G |
Lair1 |
leukocyte-associated immunoglobulin-like receptor 1 |
increases expression |
ISO |
Am 580 results in increased expression of LAIR1 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 1:70,068,571...70,187,851
Ensembl chr 1:70,157,681...70,185,807
|
|
G |
Lrp11 |
LDL receptor related protein 11 |
decreases expression |
ISO |
Am 580 results in decreased expression of LRP11 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 1:2,048,307...2,108,115
Ensembl chr 1:2,079,438...2,108,110
|
|
G |
Man1c1 |
mannosidase, alpha, class 1C, member 1 |
decreases expression |
ISO |
Am 580 results in decreased expression of MAN1C1 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 5:146,774,282...146,913,257
Ensembl chr 5:146,775,842...146,913,421
|
|
G |
Map3k6 |
mitogen-activated protein kinase kinase kinase 6 |
decreases expression |
ISO |
Am 580 results in decreased expression of MAP3K6 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 5:145,440,126...145,452,213
Ensembl chr 5:145,440,346...145,452,212
|
|
G |
Map4k1 |
mitogen activated protein kinase kinase kinase kinase 1 |
decreases expression |
ISO |
Am 580 results in decreased expression of MAP4K1 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 1:84,270,951...84,292,496
Ensembl chr 1:84,271,069...84,292,493
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
ISO |
[Am 580 co-treated with Retinoids] results in increased phosphorylation of and results in increased activity of MAPK1 protein |
CTD |
PMID:15383624 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO |
[Am 580 co-treated with Retinoids] results in increased phosphorylation of and results in increased activity of MAPK3 protein |
CTD |
PMID:15383624 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Metrn |
meteorin, glial cell differentiation regulator |
decreases expression |
ISO |
Am 580 results in decreased expression of METRN mRNA |
CTD |
PMID:16982809 |
|
NCBI chr10:14,816,684...14,818,702
Ensembl chr10:14,816,572...14,818,701
|
|
G |
Mgat4c |
MGAT4 family, member C |
decreases expression |
ISO |
Am 580 results in decreased expression of MGAT4C mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 7:36,709,564...37,485,810
Ensembl chr 7:37,260,321...37,474,571
|
|
G |
Myorg |
myogenesis regulating glycosidase |
decreases expression |
ISO |
Am 580 results in decreased expression of MYORG mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 5:56,654,257...56,664,467
Ensembl chr 5:56,648,643...56,664,440
|
|
G |
Ndrg2 |
NDRG family member 2 |
decreases expression |
ISO |
Am 580 results in decreased expression of NDRG2 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr15:24,600,981...24,609,621
Ensembl chr15:24,600,982...24,609,626
|
|
G |
Nphs1 |
NPHS1 adhesion molecule, nephrin |
increases expression |
ISO |
Am580 increases expression of Nphs1 mRNA in podocytes |
RGD |
PMID:22125642 |
RGD:40902998 |
NCBI chr 1:85,720,812...85,749,079
Ensembl chr 1:85,720,812...85,749,078
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
multiple interactions increases activity |
ISO |
Am 580 inhibits the reaction [Chenodeoxycholic Acid results in increased activity of NR1H4 protein] Am 580 results in increased activity of NR1H4 protein |
CTD |
PMID:25257666 |
|
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
|
|
G |
Nrip1 |
nuclear receptor interacting protein 1 |
increases expression |
ISO |
Am 580 results in increased expression of NRIP1 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr11:14,895,843...14,979,490
Ensembl chr11:14,895,553...14,981,761
|
|
G |
Nrip3 |
nuclear receptor interacting protein 3 |
increases expression |
ISO |
Am 580 results in increased expression of NRIP3 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 1:163,789,738...163,815,036
Ensembl chr 1:163,789,738...163,815,600
|
|
G |
Nudt7 |
nudix hydrolase 7 |
decreases expression |
ISO |
Am 580 results in decreased expression of NUDT7 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr19:42,125,679...42,151,198
Ensembl chr19:42,125,711...42,151,081
|
|
G |
Oas2 |
2'-5' oligoadenylate synthetase 2 |
multiple interactions increases expression |
ISO |
Ro 41-5253 inhibits the reaction [Am 580 results in increased expression of OAS2 mRNA] |
CTD |
PMID:16636311 |
|
NCBI chr12:35,802,824...35,830,778
Ensembl chr12:35,806,759...35,829,371
|
|
G |
Ocln |
occludin |
increases expression |
ISO |
Am 580 results in increased expression of OCLN mRNA |
CTD |
PMID:16982755 |
|
NCBI chr 2:31,657,217...31,707,466
Ensembl chr 2:31,657,220...31,764,150
|
|
G |
Olr1 |
oxidized low density lipoprotein receptor 1 |
increases expression |
ISO |
Am 580 results in increased expression of OLR1 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 4:162,926,436...162,949,057
Ensembl chr 4:162,926,439...162,948,523
|
|
G |
Oma1 |
OMA1 zinc metallopeptidase |
increases expression |
ISO |
Am 580 results in increased expression of OMA1 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 5:118,083,728...118,136,980
Ensembl chr 5:118,083,728...118,136,980
|
|
G |
Pald1 |
phosphatase domain containing, paladin 1 |
decreases expression |
ISO |
Am 580 results in decreased expression of PALD1 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr20:29,269,814...29,334,850
Ensembl chr20:29,270,193...29,334,858
|
|
G |
Papss2 |
3'-phosphoadenosine 5'-phosphosulfate synthase 2 |
increases expression |
ISO |
Am 580 results in increased expression of PAPSS2 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 1:230,454,314...230,539,332
Ensembl chr 1:230,454,426...230,539,331
|
|
G |
Pdlim2 |
PDZ and LIM domain 2 |
decreases expression |
ISO |
Am 580 results in decreased expression of PDLIM2 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr15:45,235,421...45,250,187
Ensembl chr15:45,237,477...45,249,242
|
|
G |
Pdlim4 |
PDZ and LIM domain 4 |
decreases expression |
ISO |
Am 580 results in decreased expression of PDLIM4 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr10:38,198,686...38,212,935
Ensembl chr10:38,198,689...38,212,938
|
|
G |
Pheta1 |
PH domain containing endocytic trafficking adaptor 1 |
decreases expression |
ISO |
Am 580 results in decreased expression of PHETA1 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr12:34,711,831...34,717,601
Ensembl chr12:34,711,810...34,717,081
|
|
G |
Phlda2 |
pleckstrin homology-like domain, family A, member 2 |
decreases expression |
ISO |
Am 580 results in decreased expression of PHLDA2 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 1:198,696,897...198,699,292
Ensembl chr 1:198,696,897...198,697,836
|
|
G |
Plbd1 |
phospholipase B domain containing 1 |
increases expression |
ISO |
Am 580 results in increased expression of PLBD1 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 4:169,472,983...169,529,277
Ensembl chr 4:169,472,983...169,529,277
|
|
G |
Plpp3 |
phospholipid phosphatase 3 |
increases expression |
ISO |
Am 580 results in increased expression of PLPP3 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 5:119,927,085...120,002,206
Ensembl chr 5:119,927,085...120,002,205
|
|
G |
Pon2 |
paraoxonase 2 |
decreases expression |
ISO |
Am 580 results in decreased expression of PON2 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 4:33,389,702...33,425,186
Ensembl chr 4:33,389,714...33,425,248
|
|
G |
Pram1 |
PML-RARA regulated adaptor molecule 1 |
increases expression |
ISO |
Am 580 results in increased expression of PRAM1 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 7:14,428,548...14,438,081
Ensembl chr 7:14,420,165...14,438,166
|
|
G |
Qprt |
quinolinate phosphoribosyltransferase |
decreases expression |
ISO |
Am 580 results in decreased expression of QPRT mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 1:181,718,189...181,733,486
Ensembl chr 1:181,718,190...181,733,486
|
|
G |
Rab15 |
RAB15, member RAS oncogene family |
decreases expression |
ISO |
Am 580 results in decreased expression of RAB15 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 6:95,499,584...95,524,073
Ensembl chr 6:95,499,587...95,523,942
|
|
G |
Rab20 |
RAB20, member RAS oncogene family |
increases expression |
ISO |
Am 580 results in increased expression of RAB20 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr16:78,019,337...78,043,529
Ensembl chr16:78,019,337...78,043,529
|
|
G |
Rap1gap |
Rap1 GTPase-activating protein |
decreases expression |
ISO |
Am 580 results in decreased expression of RAP1GAP mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 5:149,873,987...149,939,254
Ensembl chr 5:149,892,019...149,939,253
|
|
G |
Rara |
retinoic acid receptor, alpha |
increases expression decreases expression multiple interactions |
ISO |
Am 580 results in increased expression of RARA protein Am 580 results in decreased expression of RARA protein 2-bromopalmitate inhibits the reaction [Am 580 results in decreased expression of RARA protein]; Am 580 binds to and results in increased activity of RARA protein; Am 580 inhibits the reaction [Ro 41-5253 results in decreased activity of RARA protein] |
CTD |
PMID:10779427 PMID:16178010 PMID:16636311 PMID:17290005 PMID:30076181 |
|
NCBI chr10:83,883,490...83,928,932
Ensembl chr10:83,893,384...83,928,142
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
multiple interactions |
ISO |
[Am 580 co-treated with Retinoids] results in decreased phosphorylation of RB1 protein |
CTD |
PMID:15383624 |
|
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
|
|
G |
Rbp1 |
retinol binding protein 1 |
increases expression |
ISO |
Am 580 results in increased expression of RBP1 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 8:99,025,218...99,046,740
Ensembl chr 8:99,025,206...99,046,743
|
|
G |
Reps2 |
RALBP1 associated Eps domain containing 2 |
decreases expression |
ISO |
Am 580 results in decreased expression of REPS2 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr X:32,049,455...32,322,317
Ensembl chr X:32,049,399...32,317,414
|
|
G |
Rflnb |
refilin B |
increases expression |
ISO |
Am 580 results in increased expression of RFLNB mRNA |
CTD |
PMID:16982809 |
|
NCBI chr10:60,893,693...60,899,970
Ensembl chr10:60,893,713...60,899,976
|
|
G |
Rfxap |
regulatory factor X-associated protein |
decreases expression |
ISO |
Am 580 results in decreased expression of RFXAP mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 2:139,008,052...139,012,235
Ensembl chr 2:139,008,055...139,012,259
|
|
G |
Rhobtb3 |
Rho-related BTB domain containing 3 |
increases expression |
ISO |
Am 580 results in increased expression of RHOBTB3 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 2:5,363,388...5,419,164
Ensembl chr 2:5,363,388...5,419,041
|
|
G |
Rxra |
retinoid X receptor alpha |
increases activity |
ISO |
Am 580 results in increased activity of RXRA protein |
CTD |
PMID:21543282 |
|
NCBI chr 3:10,989,832...11,076,366
Ensembl chr 3:10,989,832...11,073,712
|
|
G |
Sel1l3 |
SEL1L family member 3 |
increases expression |
ISO |
Am 580 results in increased expression of SEL1L3 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr14:57,775,515...57,882,076
Ensembl chr14:57,775,501...57,882,644
|
|
G |
Selplg |
selectin P ligand |
decreases expression |
ISO |
Am 580 results in decreased expression of SELPLG mRNA |
CTD |
PMID:16982809 |
|
NCBI chr12:42,796,690...42,809,908
Ensembl chr12:42,796,580...42,812,585
|
|
G |
Slc26a11 |
solute carrier family 26 member 11 |
increases expression |
ISO |
Am 580 results in increased expression of SLC26A11 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr10:104,613,498...104,635,873
Ensembl chr10:104,613,564...104,635,970
|
|
G |
Slitrk4 |
SLIT and NTRK-like family, member 4 |
increases expression |
ISO |
Am 580 results in increased expression of SLITRK4 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr X:142,706,495...142,718,968
Ensembl chr X:142,706,338...142,718,575
|
|
G |
Snai3 |
snail family transcriptional repressor 3 |
increases expression |
ISO |
Am 580 results in increased expression of SNAI3 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr19:50,516,771...50,529,295
Ensembl chr19:50,516,771...50,523,486
|
|
G |
Ssmem1 |
serine-rich single-pass membrane protein 1 |
decreases expression |
ISO |
Am 580 results in decreased expression of SSMEM1 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 4:59,128,730...59,139,029
Ensembl chr 4:59,128,730...59,145,007
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
multiple interactions |
ISO |
Am 580 results in increased phosphorylation of and results in increased activity of STAT1 protein; Ro 41-5253 inhibits the reaction [Am 580 results in increased phosphorylation of and results in increased activity of STAT1 protein] |
CTD |
PMID:16085646 |
|
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
|
|
G |
Stra6 |
signaling receptor and transporter of retinol STRA6 |
increases expression |
EXP |
Am580 increases expression of Stra6 mRNA in lung |
RGD |
PMID:28734946 |
RGD:155631297 |
NCBI chr 8:58,548,899...58,568,861
Ensembl chr 8:58,549,736...58,568,860
|
|
G |
Sts |
steroid sulfatase |
increases activity |
ISO |
Am 580 results in increased activity of STS protein |
CTD |
PMID:16178010 |
|
NCBI chr X:42,225,131...42,233,403
Ensembl chr X:42,225,372...42,233,402
|
|
G |
Synpo |
synaptopodin |
increases expression |
ISO |
AM580 increases expression of Synpo mRNA in podocytes |
RGD |
PMID:22125642 |
RGD:40902998 |
NCBI chr18:54,048,299...54,106,388
Ensembl chr18:54,026,152...54,102,126
|
|
G |
Tacstd2 |
tumor-associated calcium signal transducer 2 |
decreases expression |
ISO |
Am 580 results in decreased expression of TACSTD2 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 4:96,707,950...96,709,650
Ensembl chr 4:96,707,951...96,709,650
|
|
G |
Tbc1d2 |
TBC1 domain family, member 2 |
increases expression |
ISO |
Am 580 results in increased expression of TBC1D2 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 5:60,884,114...60,931,717
Ensembl chr 5:60,884,124...60,931,352
|
|
G |
Tbl1x |
transducin (beta)-like 1 X-linked |
decreases expression |
ISO |
Am 580 results in decreased expression of TBL1X mRNA |
CTD |
PMID:16982809 |
|
NCBI chr X:41,574,558...41,731,117
Ensembl chr X:41,576,047...41,731,101
|
|
G |
Tbl2 |
transducin (beta)-like 2 |
increases expression |
ISO |
Am 580 results in increased expression of TBL2 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr12:21,517,600...21,531,896
Ensembl chr12:21,520,682...21,531,896
|
|
G |
Tert |
telomerase reverse transcriptase |
multiple interactions |
ISO |
[Am 580 co-treated with Retinoids] results in decreased expression of TERT mRNA |
CTD |
PMID:16482212 |
|
NCBI chr 1:29,637,213...29,659,561
Ensembl chr 1:29,637,506...29,659,561
|
|
G |
Tgm2 |
transglutaminase 2 |
multiple interactions increases activity increases expression |
ISO |
[Am 580 co-treated with CD 2425] results in increased activity of TGM2 protein Am 580 results in increased activity of TGM2 protein Am 580 results in increased expression of TGM2 mRNA |
CTD |
PMID:2884032 PMID:9516142 PMID:16982809 |
|
NCBI chr 3:146,772,684...146,801,924
Ensembl chr 3:146,772,687...146,801,981
|
|
G |
Thbs3 |
thrombospondin 3 |
increases expression |
ISO |
Am 580 results in increased expression of THBS3 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 2:174,621,788...174,633,594
Ensembl chr 2:174,621,812...174,633,594
|
|
G |
Tmem14a |
transmembrane protein 14A |
decreases expression |
ISO |
Am 580 results in decreased expression of TMEM14A mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 9:23,640,594...23,652,379
Ensembl chr 9:23,733,039...23,734,463 Ensembl chr 9:23,733,039...23,734,463
|
|
G |
Tnf |
tumor necrosis factor |
increases activity |
ISO |
Am 580 results in increased activity of TNF protein |
CTD |
PMID:15703382 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfsf10 |
TNF superfamily member 10 |
increases activity |
ISO |
Am 580 results in increased activity of TNFSF10 protein |
CTD |
PMID:15703382 |
|
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
|
|
G |
Tnfsf12 |
TNF superfamily member 12 |
decreases expression |
ISO |
Am 580 results in decreased expression of TNFSF12 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr10:54,403,870...54,413,213
Ensembl chr10:54,403,870...54,413,213
|
|
G |
Tns1 |
tensin 1 |
decreases expression |
ISO |
Am 580 results in decreased expression of TNS1 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 9:75,491,886...75,702,853
Ensembl chr 9:75,495,814...75,703,225
|
|
G |
Zbtb7b |
zinc finger and BTB domain containing 7B |
decreases expression |
ISO |
Am 580 results in decreased expression of ZBTB7B mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 2:174,795,831...174,811,980
Ensembl chr 2:174,797,453...174,814,236
|
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression multiple interactions |
EXP |
ioversol results in increased expression of BAX mRNA Irbesartan inhibits the reaction [ioversol results in increased expression of BAX mRNA] |
CTD |
PMID:16828304 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions decreases expression |
EXP |
Irbesartan inhibits the reaction [ioversol results in decreased expression of BCL2 mRNA] |
CTD |
PMID:16828304 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Casp3 |
caspase 3 |
increases cleavage multiple interactions |
EXP |
ioversol results in increased cleavage of CASP3 protein 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [ioversol results in increased cleavage of CASP3 protein] |
CTD |
PMID:19136047 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Cycs |
cytochrome c, somatic |
increases expression multiple interactions |
EXP |
ioversol results in increased expression of CYCS protein 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [ioversol results in increased expression of CYCS protein] |
CTD |
PMID:19136047 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Hexb |
hexosaminidase subunit beta |
increases secretion |
ISO |
ioversol results in increased secretion of HEXB protein |
CTD |
PMID:34774977 |
|
NCBI chr 2:28,483,997...28,504,165
Ensembl chr 2:28,484,012...28,504,223
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
decreases phosphorylation |
ISO |
ioversol results in decreased phosphorylation of MAPK1 protein |
CTD |
PMID:34774977 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
decreases phosphorylation |
ISO |
ioversol results in decreased phosphorylation of MAPK3 protein |
CTD |
PMID:34774977 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO |
4-amylcinnamoylanthranilic acid inhibits the reaction [Buthionine Sulfoximine results in increased activity of CASP3 protein] 4-amylcinnamoylanthranilic acid inhibits the reaction [Eicosapentaenoic Acid promotes the reaction [Cisplatin results in increased activity of CASP3 protein]] |
CTD |
PMID:33309544 PMID:35395232 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
multiple interactions |
ISO |
4-amylcinnamoylanthranilic acid inhibits the reaction [Eicosapentaenoic Acid promotes the reaction [Cisplatin results in increased activity of CASP8 protein]] |
CTD |
PMID:35395232 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
ISO |
4-amylcinnamoylanthranilic acid inhibits the reaction [Buthionine Sulfoximine results in increased activity of CASP9 protein] 4-amylcinnamoylanthranilic acid inhibits the reaction [Eicosapentaenoic Acid promotes the reaction [Cisplatin results in increased activity of CASP9 protein]] |
CTD |
PMID:33309544 PMID:35395232 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Slc13a2 |
solute carrier family 13 member 2 |
multiple interactions |
ISO |
[4-amylcinnamoylanthranilic acid results in decreased activity of SLC13A2 protein] which results in decreased susceptibility to diethylene glycol metabolite |
CTD |
PMID:21856646 |
|
NCBI chr10:63,291,813...63,319,127
Ensembl chr10:63,291,815...63,319,127
|
|
G |
Trpm2 |
transient receptor potential cation channel, subfamily M, member 2 |
multiple interactions decreases activity |
ISO EXP |
4-amylcinnamoylanthranilic acid inhibits the reaction [Adenosine Diphosphate Ribose results in increased activity of TRPM2 protein]; 4-amylcinnamoylanthranilic acid inhibits the reaction [Cisplatin promotes the reaction [Adenosine Diphosphate Ribose results in increased activity of TRPM2 protein]]; 4-amylcinnamoylanthranilic acid inhibits the reaction [Eicosapentaenoic Acid promotes the reaction [Adenosine Diphosphate Ribose results in increased activity of TRPM2 protein]]; 4-amylcinnamoylanthranilic acid inhibits the reaction [Eicosapentaenoic Acid promotes the reaction [Cisplatin promotes the reaction [Adenosine Diphosphate Ribose results in increased activity of TRPM2 protein]]] 4-amylcinnamoylanthranilic acid results in decreased activity of TRPM2 protein 4-amylcinnamoylanthranilic acid inhibits the reaction [[Buthionine Sulfoximine co-treated with Adenosine Diphosphate Ribose] results in increased activity of TRPM2 protein]; 4-amylcinnamoylanthranilic acid inhibits the reaction [Adenosine Diphosphate Ribose results in increased activity of TRPM2 protein] |
CTD |
PMID:18204483 PMID:30229906 PMID:33309544 PMID:34958835 PMID:35395232 |
|
NCBI chr20:10,703,568...10,753,189
Ensembl chr20:10,707,014...10,753,181
|
|
|
G |
Jak2 |
Janus kinase 2 |
multiple interactions |
ISO |
S3I-201 inhibits the reaction [Rapamycin increases phosphorylation of JAK2 protein in lung epithelium] |
RGD |
PMID:30755242 |
RGD:149735343 |
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
|
|
|
G |
Acvr1 |
activin A receptor type 1 |
decreases expression affects expression multiple interactions |
EXP |
tranilast inhibits the reaction [balloon angioplasty increases mRNA expression in rat carotid artery] tranilast inhibits the reaction [TGF-b1 increases mRNA expression in rat carotid artery smooth muscle cell culture] tranilast inhibits the reaction [PDGF-BB increases mRNA expression in rat carotid artery smooth muscle cell culture] |
RGD |
PMID:9622270 PMID:9622270 PMID:9622270 |
RGD:329845558, RGD:329845558, RGD:329845558 |
NCBI chr 3:42,978,558...43,097,892
Ensembl chr 3:42,978,561...43,098,241
|
|
G |
Ahr |
aryl hydrocarbon receptor |
increases response to substance multiple interactions increases expression |
ISO |
AHR protein results in increased susceptibility to tranilast AHR protein promotes the reaction [tranilast results in increased expression of AHR mRNA]; AHR protein promotes the reaction [tranilast results in increased expression of CYP1A1 mRNA]; tranilast promotes the reaction [AHR protein binds to CYP1A1 promoter] |
CTD |
PMID:25826687 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Casp8 |
caspase 8 |
multiple interactions |
EXP |
tranilast inhibits the reaction [Cisplatin results in increased expression of CASP8 protein] |
CTD |
PMID:34047436 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
decreases expression |
ISO |
tranilast results in decreased expression of CXCR4 mRNA |
CTD |
PMID:25826687 |
|
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions increases expression |
ISO |
AHR protein promotes the reaction [tranilast results in increased expression of CYP1A1 mRNA]; tranilast promotes the reaction [AHR protein binds to CYP1A1 promoter] |
CTD |
PMID:25826687 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
affects expression |
ISO |
tranilast affects the expression of CYP1B1 mRNA |
CTD |
PMID:25826687 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
multiple interactions |
ISO |
tranilast inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate] |
CTD |
PMID:23769903 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Itgav |
integrin subunit alpha V |
decreases expression |
EXP |
tranilast inhibits the reaction [balloon angioplasty increases mRNA expression in rat carotid artery] |
RGD |
PMID:9622270 |
RGD:329845558 |
NCBI chr 3:68,838,514...68,926,653
Ensembl chr 3:68,838,189...68,926,639
|
|
G |
Itgb3 |
integrin subunit beta 3 |
decreases expression |
EXP |
tranilast inhibits the reaction [balloon angioplasty increases mRNA expression in rat carotid artery] |
RGD |
PMID:9622270 |
RGD:329845558 |
NCBI chr10:89,509,917...89,564,679
Ensembl chr10:89,509,989...89,564,679
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
EXP |
tranilast inhibits the reaction [Cisplatin results in increased expression of RELA protein] |
CTD |
PMID:34047436 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Slc22a8 |
solute carrier family 22 member 8 |
multiple interactions |
EXP |
tranilast inhibits the reaction [SLC22A8 protein results in increased uptake of Methotrexate]; tranilast inhibits the reaction [SLC22A8 protein results in increased uptake of Penicillin G] |
CTD |
PMID:35019195 |
|
NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
decreases expression |
EXP |
tranilast inhibits the reaction [balloon angioplasty increases mRNA expression in rat carotid artery] |
RGD |
PMID:9622270 |
RGD:329845558 |
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tgfb3 |
transforming growth factor, beta 3 |
decreases expression |
EXP |
tranilast inhibits the reaction [balloon angioplasty increases mRNA expression in rat carotid artery] |
RGD |
PMID:9622270 |
RGD:329845558 |
NCBI chr 6:105,704,058...105,726,661
Ensembl chr 6:105,704,236...105,726,564
|
|
G |
Tgfbr1 |
transforming growth factor, beta receptor 1 |
decreases expression affects expression multiple interactions |
EXP |
tranilast inhibits the reaction [balloon angioplasty increases mRNA expression in rat carotid artery] tranilast inhibits the reaction [TGF-b1 increases mRNA expression in rat carotid artery smooth muscle cell culture] tranilast inhibits the reaction [PDGF-BB increases mRNA expression in rat carotid artery smooth muscle cell culture] |
RGD |
PMID:9622270 PMID:9622270 PMID:9622270 |
RGD:329845558, RGD:329845558, RGD:329845558 |
NCBI chr 5:61,653,773...61,710,777
Ensembl chr 5:61,653,233...61,710,777
|
|
G |
Tgfbr2 |
transforming growth factor, beta receptor 2 |
decreases expression affects expression multiple interactions |
EXP |
tranilast inhibits the reaction [balloon angioplasty increases mRNA expression in rat carotid artery] tranilast inhibits the reaction [TGF-b1 increases mRNA expression in rat carotid artery smooth muscle cell culture] tranilast inhibits the reaction [PDGF-BB increases mRNA expression in rat carotid artery smooth muscle cell culture] |
RGD |
PMID:9622270 PMID:9622270 PMID:9622270 |
RGD:329845558, RGD:329845558, RGD:329845558 |
NCBI chr 8:115,794,537...115,883,615
Ensembl chr 8:115,794,537...115,883,228
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
EXP |
tranilast inhibits the reaction [Cisplatin results in increased expression of TNF protein] |
CTD |
PMID:34047436 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfsf10 |
TNF superfamily member 10 |
multiple interactions |
EXP |
tranilast inhibits the reaction [Cisplatin results in increased expression of TNFSF10 protein] |
CTD |
PMID:34047436 |
|
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
|
|
G |
Trpv2 |
transient receptor potential cation channel, subfamily V, member 2 |
decreases activity |
ISO |
tranilast results in decreased activity of TRPV2 protein |
CTD |
PMID:30235802 |
|
NCBI chr10:47,265,524...47,294,263
Ensembl chr10:47,272,931...47,294,260
|
|